View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
November 2021
COVID-19News | Clinical knowledge summaries | Into practice | Events | Get involved | Announcements


Updates to our guideline on managing the long-term effects of COVID-19

We have added new recommendations and updated existing recommendations to our rapid guideline on managing the long-term effects of COVID-19. These cover:

We have reviewed the evidence on case definitions, referral to services, children and young people, the impact of vaccines on the long-term effects of COVID-19, signs, symptoms and prevalence and risk factors. We have also updated the list of common symptoms to emphasise that these may be different for children.

We are continuously updating our long-term effects of COVID-19 guideline to incorporate the latest evidence and keep abreast of new developments. We’ll highlight recent updates in this monthly email communication, or you can keep up to date on the latest live changes through our website.


Doctor or physician recommend pills medical prescription to male patient

Draft guideline on safe prescribing and withdrawal management of dependence-forming medicines

Our draft guideline on safe prescribing and withdrawal management advises doctors, nurses and pharmacists to discuss with patients the risks of prescribing certain medicines such as opioids, sleeping pills and antidepressants. People who are taking, or considering coming off dependence forming drugs should have regular review meetings with their doctor, nurse or pharmacist. Consultation on our draft recommendations is open until Thursday 2 December 2021.

ME/CFS woman lying on the bed very tired

ME/CFS guideline outlines steps for improved diagnosis and management

We’ve published an updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS). Our evidence-based recommendations make it clear that any programme based on fixed incremental increases in physical activity or exercise should not be offered. The guideline also recommends cognitive behavioural therapy should only be offered to support people who live with ME/CFS to manage their symptoms, improve their functioning and reduce the distress associated with having a chronic illness.

Catch up on all our latest news articles

Clinical knowledge summaries

New topics and updates on the site since the start of October include:

  • Anaemia – iron deficiency. The topic has been updated in line with the British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults 2021.
  • Candida – female genital. The treatment regimens for acute vulvovaginal candidiasis and for women with uncontrolled diabetes or other causes of immunocompromise have been updated, in line with the British Association for Sexual Health and HIV national guideline on vulvovaginal candidiasis 2019. The scenarios on 'severe infection' and 'uncontrolled diabetes or immunocompromised' have been deleted, and their content incorporated into other scenarios, for clarity and ease of navigation.
  • Immunisations – seasonal influenza. A new recommendation has been added to this topic. Children aged over 2 years, with a history of severe anaphylaxis to egg, who have previously required intensive care management in hospital, can be offered the egg-free cell-based quadrivalent influenza vaccine. This is an alternative to referral to a specialist for immunisation in hospital.
  • Non-alcoholic fatty liver disease. Content has been updated on prevalence, aetiology, complications, diagnosis, and management.
  • Tiredness/fatigue in adults. Updated to include recommendations from the NICE guideline on myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS): diagnosis and management 2021. Changes include the range of blood tests that are recommended in assessing a person with suspected CFS, the timescale for referral, the range of supportive measures that should be considered, and the follow up recommended in primary care.
CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover over 1,000 clinical presentations or patient scenarios, free to access in the UK.

Into practice

NEW impact report on learning disabilities

Our latest impact report explores how our guidance for people with a learning disability has been implemented across the health and social care system over recent years. Data collected shows that while some positive change has occurred, health inequality persists. Recommendations to address this challenge include a range of cross-system actions in priority areas that aim to support improving health for people with a learning disability.

NICE impact reports review how our guidance is being used to improve health and care outcomes. The reports are based on data showing the uptake of our guidance and quality statement measures from national audits, reports, surveys and indicator frameworks.

Read learning disabilities impact report

Get involved

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for GPs, a physiotherapist, and a specialist mental health pharmacist, to join our:

Our guidance and quality standards are developed by independent committees. Join us and have an active role in producing a guideline or quality standard.
See all our committee vacancies

Observe a meeting

We’re currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Friday 10 December 2021 – Medical technologies advisory committee
    Registration closes Friday 3 December 2021.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings


Professor Bee Wee

Professor Bee Wee CBE appointed new non-executive director

The Department of Health and Social Care has announced the appointment of Professor Bee Wee CBE as a new non-executive director at NICE. Professor Bee Wee is national clinical director for end of life care for NHS England and NHS Improvement.


unsubscribe from this list